Differential transcriptional invasion signatures from patient derived organoid models define a functional prognostic tool for head and neck cancer — Patrick W.B. Derksen (2023) | RDL Network
Differential transcriptional invasion signatures from patient derived organoid models define a functional prognostic tool for head and neck cancer
Preprint 2023 en
Authors
PD
Patrick W.B. Derksen
PH
P. M. Haughton
SP
Stefan Prekovic
Abstract
1 min read
<title>Abstract</title> Clinical outcome for patients suffering from head and neck squamous cell carcinoma (HNSCC) remains poor. This is mostly due to highly invasive tumors that cause loco-regional relapses after initial therapeutic intervention. The molecular pathways governing the detrimental invasive growth modes in HNSCC remain however understudied. Here, we have established HNSCC patient derived organoid (PDO) models that recapitulate 3-dimensional invasion <italic>in vitro</italic>. Single cell mRNA sequencing was applied to study the differences between non-invasive and invasive conditions, and in a collective versus single cell invading PDO model. Differential expression analysis under invasive conditions in Collagen gels reveals an overall upregulation of a YAP-centered transcriptional program, irrespective of the invasion mode. However, we find that collectively invading HNSCC PDO cells show elevated levels of YAP transcription targets when compared to single cell invasion. Also, collectively invading cells are characterized by increased nuclear translocation of YAP within the invasive strands, which coincides with Collagen-I matrix alignment at the invasive front. Using gene set enrichment analysis, we identify immune cell-like migratory pathways in the single cell invading HNSCC PDO, while collective invasion is characterized by overt upregulation of adhesion and migratory pathways. Lastly, based on a clinical head and neck cancer cohort, we demonstrate that the identified collective invasion signature provides a candidate prognostic platform for survival in HNSCC. By uncoupling collective and single cell invasive programs, we have established invasion signatures that may guide new therapeutic options.
Peter D. Haughton, Theofilos Chalkiadakis, Gerben E. Breimer, Else Driehuis, Hans Clevers, Stefan Willems, Stefan Prekovic, Patrick W.B. Derksen, Peter D. Haughton, Theofilos Chalkiadakis, Gerben E. Breimer, Else Driehuis, Hans Clevers, Stefan Willems, Stefan Prekovic, Patrick W.B. Derksen
Julie Le Naour, Zsófia Sztupinszki, Vincent Carbonnier, Odile Casiraghi, Virginie Marty, Lorenzo Galluzzi, Zoltán Szállási, Guido Guido Kroemer, Erika Vacchelli
Paolo Boffetta, Richard B. Hayes, Samantha Sartori, Yuan-Chin A. Lee, Joshua Muscat, Andrew F. Olshan, Deborah M. Winn, Xavier Castellsagué, Zuo‐Feng Zhang, Hal Morgenstern, Chu Chen, Stephen M. Schwartz, Thomas L. Vaughan, Victor Wünsch‐Filho, Mark P. Purdue, Sérgio Koifman, María Paula Curado, Marta Vilensky, Maura L. Gillison, Leticia Fernández, Ana Maria B. Menezes, Alexander W. Daudt, Stimson Schantz,
Discussion(0)
No comments yet. Be the first to comment.